NCT07064343 Stand By Me: Anti-Drug Elite Adventure-Based Training Program
| NCT ID | NCT07064343 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Hong Kong Polytechnic University |
| Condition | Drug Abuse Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-09-09 |
| Primary Completion | 2025-09-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-09-09 with a primary completion date of 2025-09-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project is expected to establish a network of resilient young people with good anti-drug knowledge to mobilize them to assist in current or future anti-drug work, expanding the antidrug capacity of our community. After the project, it is also anticipated that people in this network will continue to assist in the anti-drug work.
Eligibility Criteria
Inclusion Criteria: 1. post-secondary or tertiary education students, 2. aged 18 - 35, 3. able to speak in Cantonese and write in Chinese. Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07064343 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Drug Abuse Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07064343 currently recruiting?
Yes, NCT07064343 is actively recruiting participants. Contact the research team at kw-katherine.lam@polyu.edu.hk for enrollment information.
Where is the NCT07064343 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07064343 clinical trial?
NCT07064343 is sponsored by The Hong Kong Polytechnic University. The trial plans to enroll 200 participants.